Summary
The effects of the immunosuppressive drug cyclosporin A (CsA) were evaluated on ROS 17/2.8 cells in vitro. ROS cells were treated with CsA (0, 0.5, 1.0, 5.0 μg/ml) for 3 days with and without bovine parathyroid hormone (bPTH) (1–34) 10 nM. CsA at 0.5, 1.0, 5.0 μg/ml without PTH and at 5.0 μg/ml in the presence of PTH significantly inhibited proliferation, as determined by a tetrazolium colorimetric assay. In addition, ROS cell number was significantly reduced at 3 and 4 days with CsA (5.0 μg/ml) without affecting cell viability. Incorporation of [3H]-thymidine into DNA was significantly reduced by 3.0 and 5.0 μg/ml CsA after 12 and 24 hours exposure. Basal and 1,25-dihydroxyvitamin D3-stimulated alkaline phosphatase levels in confluent ROS cells were reduced (P<0.05) with CsA (1.0 and 3.0 μg/ml). Pretreatment of ROS 17/2.8 cells with CsA did not alter PTH-stimulated cAMP levels or [125I]-PTHrP binding to ROS cells. CsA treatment of ROS 17/2.8 cells induced a spindle-shaped appearance with loss of attachment in confluent cultures. When ROS cells were cultured in CsA-containing media, cellular attachment at 6 and 12 hours was reduced (P<0.05) compared with untreated ROS cells. These findings indicate that CsA was capable of inhibiting proliferation, cell number, mitogenesis, alkaline phosphatase levels, and cell attachment of ROS cells without affecting PTH binding or cAMP levels. This direct effect of CsA on osteoblasts may be important in changes of bone remodeling observed in CsA-treated humans and animals.
Similar content being viewed by others
References
Foxwell BMJ, Ruffel B (1989) The mechanisms of action of cyclosporine. Immunol Allergy Clin North Am 9:79–93
Stewart PJ, Green OC, Stern PH (1986) Cyclosporine A inhibits calcemic hormone-induced bone resorption in vitro. J Bone Miner Res 1:285–291
Klaushofer K, Hoffman O, Stewart PJ, Czerwenka E, Koller K, Peterlik M, Stern PH (1987) Cyclosporine A inhibits bone resorption in cultured neonatal mouse calvaria. J Pharmacol Exp Ther 243:584–590
McCauley LK, Rosol TJ, Stromberg PC, Capen CC (1991) Effects of interleukin-1 alpha and cyclosporin A in vivo and in vitro on bone and lymphoid tissues in mice. Toxicol Pathol 19:1–10
Chowdhury MH, Shen V, Dempster DW (1991) Effects of cyclosporine A on chick osteoclasts in vitro. Calcif Tissue Int 49:275–279
Stewart PJ, Stern PH (1989) Cyclosporines: correlation of immunosuppressive activity and inhibition of bone resorption. Calcif Tissue Int 45:222–226
Espevik T, Figari IS, Shalaby MR, Lackides GA, Lewis GD, Shepard HM, Palladino MA (1987) Inhibition of cytokine production by cyclosporin A and transforming growth factor beta. J Exp Med 166:571–576
Movsowitz C, Epstein S, Ismail F, Fallon M, Thomas S (1989) Cyclosporin A in the oophorectimized rat: unexpected severe bone resorption. J Bone Miner Res 4:393–398
Orcel P, Bielakoff J, Modrowski D, Miravet L, De Vernejoul MC (1989) Cyclosporin A induces in vivo inhibition of resorption and stimulation of formation in rat bone. J Bone Miner Res 4:387–391
Wilmink JM, Bras J, Surachno S, vHeyst JLAM, vdHorst JM (1989) Bone repair in cyclosporin-treated renal transplant patients. Transplant Proc 21:1492–1494
Li XQ, Stevenson S, Klein L, Davy DT, Shaffer JW, Goldberg VM (1991) Differential patterns of incorporation and remodeling among various types of bone grafts. Acta Anat 140:236–244
Drugge RJ, Handschumacher RE (1988) Cyclosporine—mechanism of action. Transplant Proc 20:301–309
Jenkins MK, Schwartz RH, Pardoll DM (1988) Effects of cyclosporine A on T cell development and clonal deletion. Science 241:1655–1658
Sharpe RJ, Arndt KA, Bauer SI, Maione TE (1989) Cyclosporine inhibits basic fibroblast growth factor-driven proliferation of human endothelial cells and keratinocytes. Arch Dermatol 125:1359–1362
Nicchitta CV, Kamoun M, Williamson JR (1985) Cyclosporine augments receptor-mediated cellular Ca2+ fluxes in isolated hepatocytes. J Biol Chem 260:13613–13618
Orcel P, Denne MA, De Vernejoul MC (1991) Cyclosporin A in vitro decreases bone resorption, osteoclast formation, and the fusion of cells of the monocyte-macrophage lineage. Endocrinology 128:1638–1646
Vaes G (1988) Cellular biology and biochemical mechanisms of bone resorption. Clin Orthop Rel Res 231:239–271
Majeska RJ, Rodan SB, Rodan GA (1980) Parathyroid hormoneresponsive clonal cell lines from rat osteosarcoma. Endocrinology 107:1494–1503
Hansen MB, Nielsen SE, Berg K (1989) Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119:203–210
Wrana JL, Maeno M, Hawrylshyn B, Yao KL, Domenicucci C, Sodek J (1988) Differential effects of transforming growth factor-beta on the synthesis of extracellular matrix proteins by normal fetal rat calvarial bone cell populations. J Cell Biol 106:915–924
McCauley LK, Rosol TJ, Merryman JI, Capen CC (1992) Parathyroid hormone-related protein binding to human T-cell lymphotropic virus type-I-infected lymphocytes. Endocrinology 130:300–306
Nissenson RA, Diep D, Strewler GJ (1988) Synthetic peptides comprising the amino-terminal sequence of a parathyroid hormone-like protein from human malignancies. J Biol Chem 263:12866–12871
Stewart PJ, Stern PH (1991) Interaction of cyclosporine A and calcitonin on bone resorption in vitro. Horm Metab Res 21:194–197
The Canadian Multicentre Transplant Study Group (1983) A randomized clinical trial of cyclosporine in cadaveric renal transplantation. N Engl J Med 309:809–815
Larsson EL (1980) Cyclosporin A and dexamethasone suppress T cell responses by selectively acting at distinct sites of the triggering process. J Immunol 124:2828–2833
Schweighoffer T, Schweighoffer E, Apati A, Antoni F, Molnar G, Lapis K, Banfalvi G (1991) Cytometric analysis of DNA replication inhibited by emetine and cyclosporin A. Histochemistry 96:93–97
Wong G (1990) Isolation and behavior of isolated bone-forming cells. In: Hall BK (ed) The osteoblast and osteocyte. The Telford Press, Caldwell, NJ, pp 171–192
Majeska RJ, Rodan GA (1982) The effect of 1,25(OH)2D3 on alkaline phosphatase in osteoblastic osteosarcoma cells. J Biol Chem 257:3362–3365
Skjodt H, Crawford A, Elford PR, Ihrie EE, Wood DD, Russell GG (1985) Cyclosporin A modulates interleukin-1 activity on bone in vitro. Br J Rheumatol 24:165–169
Somerman MJ, Prince CW, Butler WT, Foster RA, Moehring JM, Sauk JJ (1989) Cell attachment activity of the 44 kilodalton bone phosphoprotein is not restricted to bone cells. Matrix 9:49–54
Somerman MJ, Schiffman E, Reddi AH, Termine J (1982) Regulation of the attachment and migration of bone cells in vitro. J Periodont Res 17:527–531
Simmons DJ, Grynpas MD (1990) Mechanisms of bone formation in vivo. In: Hall BK (ed) The osteoblast and osteocyte. The Telford Press, Caldwell, NJ, pp 193–302
McSheehy PMJ, Chambers TJ (1986) Osteoblast-like cells in the presence of parathyroid hormone release soluble factor that stimulates osteoclastic bone resorption. Endocrinology 119:1654–1659
Schlosberg M, Movsowitz C, Epstein S, Ismail F, Fallon MD, Thomas S (1989) The effect of cyclosporin A administration and its withdrawal on bone mineral metabolism in the rat. Endocrinology 124:2179–2184
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McCauley, L.K., Rosol, T.J. & Capen, C.C. Effects of cyclosporin A on rat osteoblasts (ROS 17/2.8 cells) in vitro . Calcif Tissue Int 51, 291–297 (1992). https://doi.org/10.1007/BF00334490
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00334490